• Client Login
Ozmosi
  • Services
    • BEAM Clinical Trial Data
    • GCT Global Clinical Trials
    • PRYZM Pharma Product Database
    • KRYSTL Industry Scan Reporting
    • LENZ Company Pipeline Summary
    • Specialized Consulting
    • Approved Pharmaceutical Products in Use
  • About Us
  • Case Studies
  • Newsroom
  • Conference Info
  • Contact Us
Select Page
Covid-19 Clinical Trials and Where to Get Treated

Covid-19 Clinical Trials and Where to Get Treated

Nov 27, 2020 | COVID-19, Disease Area Trends

We all know the basics for fighting the COVID-19 virus, like washing our hands and staying socially distant from one another, but what about future vaccines and treatments? There is a lot of talk right now about different companies making progress and potential...
Covid-19 Clinical Trials and Where to Get Treated Update

Covid-19 Clinical Trials and Where to Get Treated Update

Oct 20, 2020 | COVID-19, Disease Area Trends

Here is a quick update on the ever-evolving world of COVID-19 trials.  Since our initial posting on this topic three weeks ago, the number of trials has grown from 100 to over 300. The number of clinical facilities with clinical trials for COVID-19 has grown from 160...

Recent Posts

  • OZMOSI Announces Strategic Partnership with Planview to Advance AI-Driven Planning in Pharmaceutical R&DMay 13, 2026
  • Pharmaceutical Portfolio Strategy in the AI Era: Why External Intelligence MattersApril 29, 2026
  • Why AI Stalls in Pharmaceutical R&D Operations (and How to Fix It)March 31, 2026
  • Who is Winning in Innovation and How are They Balancing Risk?February 28, 2026
  • How Next-Generation Probability of Success Forecasting Can Improve Clinical Trial Accuracy by 44%January 16, 2026
  • Market Overview: GLP-1 Agonists and the Obesity MarketDecember 16, 2025
  • Home
  • About Us
  • Services
  • Case Studies
  • Newsroom
  • Contact Us
  • Facebook
  • X
OZMOSI© 2025 | All Rights Reserved | Site by Webtyde